In January, Utah became the first state to let an AI renew routine prescriptions, under an agreement with another startup. Starting today, Nolla says its AI can take an acne patient in Utah from a skin scan to a new prescription, with a doctor brought in when needed.
The closest parallel is Waymo. Waymo One launched in the Phoenix suburbs in December 2018 with safety drivers still behind the wheel. Fully driverless rides opened to riders there in October 2020. Robotaxis started on easy roads, in a state that had invited them in, and built their record from there.
In medicine, acne is about as close to a sunny suburban grid as it gets. It's visual, which makes it a natural first target for a skin scan. It's common, affecting up to 50 million Americans a year by the American Academy of Dermatology's count. And specialists are scarce. The US has about 12,500 practicing dermatologists, and a 2025 AMN Healthcare survey found a 36.5-day average wait for a new-patient skin-cancer screening in big metros.
Renewing a refill repeats a decision some doctor already made.
Diagnosing the acne and picking the prescription is the visit itself, and I'd call that the bigger line to cross. It's also the visit that waits on a dermatologist's calendar.
Even the refill program drew pushback. In April, Utah's medical licensing board urged the state to halt it, and the state declined. Anything that writes new prescriptions will face harder questions, and my guess is outcome data settles them, one condition and one state at a time.
Acne could be where AI prescribing starts logging its miles.
Today, Nolla Health became the first organization in the U.S. (and possibly the world) to receive regulatory approval for an AI to issue initial prescriptions.
This makes Nolla the first ever actual end-to-end AI doctor.